Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

291.50
-4.9100-1.66%
Post-market: 291.500.00000.00%19:30 EDT
Volume:659.87K
Turnover:192.73M
Market Cap:13.92B
PE:-59.72
High:294.89
Open:291.66
Low:289.60
Close:296.41
52wk High:303.31
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:0.70
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.90
PE(LYR):-100.10

Loading ...

Charles River Exec Says Q3 Adj EPS Expected at $2.90-$3.00 - Conf Call

THOMSON REUTERS
·
Aug 05

Charles River Exec Says Continue to Expect Lower Volumes for Research Models in North America, Spending from Academic and Government Clients Has Been Constrained by Flat Nih Budgets and Slower Grant Processing - Conf Call

THOMSON REUTERS
·
Aug 05

U.S. Stocks on the MOVE-Cencora, Charles River, Twist Bioscience

Reuters
·
Aug 05

Stock Track | Charles River Laboratories Soars 8.15% in Pre-Market on Q2 Earnings Beat and Raised Guidance

Stock Track
·
Aug 05

Movement Alert|Charles River Laboratories Rises 8.06% in Pre-Market Trading, Q2 Earnings Beat Across the Board with Full-Year Guidance Raised

Market Focus
·
Aug 05

Charles River Laboratories Shares up 8.1% Premarket After Co Lifts FY Profit Forecast

THOMSON REUTERS
·
Aug 05

Charles River Lifts Profit Forecast on Improving Biotech Demand

Reuters
·
Aug 05

Charles River Laboratories Tops Q2 Revenue and Profit Estimates

Reuters
·
Aug 05

GUIDANCE: (CRL) Charles River Laboratories Expects 2026 Adjusted EPS Range $11.15 - $11.45, vs. FactSet Est of $11.11

MT Newswires Live
·
Aug 05

Earnings Flash (CRL) Charles River Laboratories Posts Fiscal Q2 Revenue $1.00B, vs. FactSet Est of $977.2M

MT Newswires Live
·
Aug 05

Charles River Q2 FY26 GAAP EPS Swings to Loss of $(0.03); Revenue Falls 2.7% to $1 Billion

Reuters
·
Aug 05

Charles River Q2 Adjusted EPS USD 3.02 Vs. IBES Estimate USD 2.74

Reuters
·
Aug 05

Charles River Outlook FY Revenue Growth -3.5 to -2.5%

THOMSON REUTERS
·
Aug 05

Charles River Outlook FY Adjusted EPS USD 11.15-11.45

THOMSON REUTERS
·
Aug 05

Charles River Q2 EPS USD -0.03

THOMSON REUTERS
·
Aug 05

Charles River Laboratories International Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
Aug 05

Press Release: Pharming Reports Second Quarter and First Half 2026 Financial Results and Revises Year-end Guidance; Strong Joenja Momentum and Near-term Clinical Readouts to Support Broader Therapeutic Use

Dow Jones
·
Jul 30

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 30

Earning Preview: Charles River Laboratories Q2 revenue expected to decrease by 1.05%, and institutional views are mixed-to-positive

Earnings Agent
·
Jul 29

Movement Alert|Charles River Laboratories Rises 7.74% in Regular Trading, CRO Sector Rallies as Multiple Banks Raise Price Targets

Market Focus
·
Jul 28